Elevra Lithium Completes Sale of E45/2364 Pegmatite Rights

Elevra Lithium (ASX:ELV, NASDAQ:ELVR) says it has completed the sale of its rights and obligations for WA tenement E45/2364 (Tabba Tabba) to Wildcat Resources. Elevra will receive $16m total plus a royalty if Wildcat defines a pegmatite resource, including A$5m cash, A$8m in Wildcat shares at $0.353, A$3m deferred cash, and contingent A$0.70/tonne.

Original reporting
Published Aug 7, 2026, 2:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 7, 2026, 2:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMergers & acquisitions
Primary signal
$ELVR
Bullish
medium confidence
Mentioned
$ELVR
Relevance
7/10
AlphAI data visualization · based on montrealgazette.com
Decision brief

The 30-second read

$ELVRBullishMed
01

Why it matters

By selling all rights, interests, and obligations in E45/2364, Elevra removes project-specific risk and receives immediate and milestone-linked consideration, while retaining only contingent exposure through royalty-like payments tied to Wildcat’s technical outcomes.

02

Market read

Deal completion with defined consideration ($5M cash at completion, $8M in Wildcat shares, $3M deferred after feasibility, and per-tonne contingent royalties) provides a concrete catalyst for Elevra’s portfolio and near-term cash outlook.

03

What to watch

Wildcat’s ability to define a pegmatite mineral resource and advance a feasibility study is the key driver of the remaining $3M deferred cash and per-tonne contingent royalties.

Relevance 7/10Novelty 7/10Timing: completed transaction reported today (Aug. 7, 2026)

Background

Elevra is a North American lithium producer with projects in Quebec, the US, and a Western Australia joint venture; E45/2364 (Tabba Tabba) is described as a non-core asset.

Company-level read

Ticker impact

$ELVRBullishMedium confidence
Context

Elevra completed the sale of its E45/2364 pegmatite rights to Wildcat for $16M plus cash and royalty-linked contingent payments.

Expected impact

Near-term sentiment likely positive due to $5M cash at completion and portfolio simplification, with longer-dated upside dependent on Wildcat’s resource and feasibility progress.

Evidence & confidence

The article discloses deal completion and specific consideration components, but does not provide Elevra’s financial impact, guidance, or any immediate production/cost changes beyond the asset sale.

Market effects

Signals continued capital reallocation among lithium developers, with smaller WA pegmatite rights being monetized via structured consideration.

Limited direct impact expected beyond Australian lithium exploration and project-rights markets.

Modest, as it is a single-asset rights sale rather than a major global lithium supply or demand shift.

Counterpoint

The headline cash is partly offset by deferred and contingent payments, so the deal may reduce upside versus retaining the rights through exploration success.

Key entities

  • Elevra Lithium Limited

    North American lithium producer that completed the sale of E45/2364 pegmatite rights to Wildcat.

  • Wildcat Resources Limited

    Buyer that assumes ownership, control, and liability for E45/2364 and will drive resource and feasibility milestones.

  • E45/2364 (Tabba Tabba)

    Western Australia pegmatite rights subject to the transaction, with payments contingent on JORC pegmatite resource definition and feasibility progress.

Related articles

$ELVRMed

Elevra Lithium Announces NAL Expansion Pre-Feasibility Study

Elevra Lithium (ASX:ELV; NASDAQ:ELVR) announced a Pre-Feasibility Study for its North American Lithium (NAL) expansion in Québec. The study projects increased annual spodumene concentrate production to 373ktpa, reduced unit costs, and a post-tax NPV of C$3,218M. The expansion is fully funded with C$366M in initial CAPEX and will be delivered in three stages, starting mid-2027.

$ELVRMed

Elevra Lithium Ltd (ASX:ELV) Corporate Presentation - Outlines Growth Strategy for North American Lithium Platform

Elevra Lithium Ltd (ASX:ELV) outlined its growth strategy for North American Lithium (NAL) in Quebec, targeting 373,000 tonnes of spodumene concentrate annually. FY26 production was 197,967 tonnes, with revenue of US$202 million. The company plans a three-stage expansion, with initial capital expenditure of US$271 million. FY27 production guidance is 198,000 to 210,000 tonnes.

$ELVRMed

Elevra Lithium Ltd (ASX:ELV) NAL Expansion Pre-Feasibility Study

Elevra Lithium (ASX:ELV, NASDAQ:ELVR) announced a Pre-Feasibility Study for its North American Lithium (NAL) expansion, targeting increased spodumene production and reduced costs. The project, fully funded at C$366M, aims to boost annual output to 373ktpa by mid-2029, with a post-tax NPV of C$3.218B. The expansion is expected to reduce LOM C1 costs to C$851/t post-expansion, according to the company.

$ELVRMed

Elevra Lithium H2 Earnings Call Highlights

Elevra Lithium reported cash of $255M at June 30, up from $47M a year earlier, with additional funding from convertible notes. NAL produced 198,000 tonnes of spodumene concentrate, down 3% YoY. Expansion plans include increasing milling capacity to 6,500 tonnes per day, with stage one expected by mid-2027. Fiscal 2027 guidance includes production of 198,000-210,000 tonnes and unit costs of $880-$950 per tonne.

$ELVRMed

Elevra Lithium Ltd (ASX:ELV) Binding Agreement Concluded with Mangrove Lithium

Elevra Lithium (ASX:ELV) has signed a binding 7-year spodumene supply agreement with Mangrove Lithium, extendable for another 7 years. The deal secures long-term local supply for Elevra's Quebec operations at market-linked prices with downside protection. Mangrove's facility, pending financing, will avoid Elevra's ocean freight costs. Both companies are backed by Canada Growth Fund.